Scandinavian ChemoTech AB B (CMOTEC B)

Sell: 4.61 SEK|Buy: 4.79 SEK|Change: 0.31 (-6.08%)

Open

5.08 SEK

Previous close

5.10 SEK

Trade high

5.08 SEK

Volume

7,238

Year high

7.76 SEK

Year low

0.88 SEK

Dividend yield

–

Market capitalisation

121.92 mn SEK

P/E ratio

–

ISIN

SE0009242654

This share can be held in a Dealing account SIPP

Share price

Performance 22/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Scandinavian ChemoTech AB B	+ 10.15
More...

Company profile

Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.